Latest MyOme News & Updates

See the latest news and media coverage for MyOme. We track all announcements, press releases, and industry mentions in real time, all in one place.

MyOme

Clinical genomic testing and analysis company

myome.com

Headquarters: Palo Alto, United States
Company type: Private company
Number of employees: 100–200
Industry: Biotechnology & Medical Research

Last updated October 8

Latest news about MyOme

In short: MyOme debuted Zenith with Natera, advanced CAD risk validation, and expanded major partnerships

Company announcements

October 8 MyOme

MyOme launches free cascade genetic testing for ADH1 families

Sponsored by BridgeBio, the program offers no-cost familial variant testing and counseling up to fourth-degree relatives of patients with confirmed Autosomal Dominant Hypocalcemia Type 1.

October 6 MyOme

MyOme releases Atlas Curated Screen tool

The service uses whole-genome sequencing to evaluate clinically actionable variants across 151 genes. Results support personalized health decisions and can be reanalyzed as science advances.

December 14, 2025 MyOme

MyOme strikes collaboration deal with Illumina including investment

The deal supports MyOme's Proactive Health Trial, which aims to show cost savings from whole-genome sequencing and AI risk models.

June 21, 2022 MyOme

MyOme secures $23M in Series B funding

The oversubscribed round led by Healthcare Venture Partners will fund commercialization of whole genome analysis platform.

Media coverage

October 8 Yahoo Finance

MyOme Launches CASRcade, a No Charge Family Cascade Genetic Testing Program for Families Affected by ADH1

MyOme today announced CASRcade, a cascade genetic testing program sponsored by BridgeBio for families affected by Autosomal Dominant Hypocalcemia Type 1 (ADH1), a rare condition...

September 23 TMCnet

MyOme and Oracle Collaborate to Advance Genomic Risk Prediction at Global Scale

"Our collaboration with Oracle is an important step toward making predictive genomics available at global scale," said Matt Rabinowitz, PhD, executive chairman of MyOme. "Pairing...

November 12, 2025 Finanznachrichten

MyOme, Inc: Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO and...

June 18, 2022 Gray Media

MyOme Secures $23M in Series B Funding to Deliver Clinical Whole Genome Insights to Help Families Manage Risk for Inherited Diseases

The oversubscribed series B financing led by Healthcare Venture Partners, added SoftBank Corp. and Natera to existing investors- Sequoia Capital, Foresite Capital, Founders Fund, among...

Never miss news about MyOme

Track MyOme and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

MyOme competitors & trending companies

Browse news for competitors to MyOme and other trending companies.